29 completed, 5 terminated, 4 unknown, 3 not yet recruiting. 29 Phase 2, 17 Phase 1, 10 Not applicable, 4 Phase 3, 1 Early Phase 1.
Follow Genistein: new trials by email Literature Review of Genistein trials Research Report on Genistein
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Genistein for the Reduction of Adverse Cardiovascular Events (GRACE) Genistein (Unconjugated Isoflavones 100), Placebo - HIV, Vascular Disease | Phase 1 / Phase 2 | Not yet recruiting | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 60 | 2026-09-30 | 2026-08-25 |
| Effectiveness of Genistein in Mild Cognitive Impairment Genistein, Control product placebo - Alzheimer Disease (AD), Mild Cognitive Impairment (MCI) | Not applicable | Not yet recruiting | Universidad Católica San Antonio de Murcia | 150 | 2026-02-01 | 2026-02-17 |
| Evaluating Metabolic and Anti-inflammatory Effect of Genistein on Post-myocardial Infarction Patients genistein - Myocardial Infarction (MI) | Not applicable | Recruiting | National Taiwan University Hospital | 73 | 2025-09-01 | 2025-08-07 |
| Exploring a Natural Solution for Childhood Obesity genistein - Obesity, Children | Phase 1 / Phase 2 | Not yet recruiting | Western University | 30 | 2025-08-01 | 2025-06-24 |
| Genistein, Equol, Cognitive Function and Mood: Acute. (GECFAMa) Genistein, Equol, Maltodextrin (Placebo) - Cognition, Mood | Not applicable | Completed | University of Reading | 53 | 2024-11-14 | 2026-08-07 |
| Genistein, Equol, Cognitive Function and Mood: Twelve-week. (GECFAMc) Equol, Genistein, Maltodextrin - Cognition, Mood | Not applicable | Completed | University of Reading | 51 | 2024-11-01 | 2026-08-03 |
| The Clinical Study on Isoflavone Genistein in Restructuring the Gut Microbiota of Hyperlipidemia Patients Genistein - Hyperlipidemia | Not applicable | Completed | Shenzhen Hospital of Southern Medical University | 36 | 2024-10-13 | 2025-03-26 |
| Genistein in trAnSthyretin recePtor Amyloid caRdiomyopathy Genistein - Amyloid Cardiomyopathy | Phase 1 / Phase 2 | Recruiting | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 20 | 2024-09-27 | 2025-06-15 |
| Cardiovascular Genistein Therapy for Heart Failure Inflammation Genistein - Heart Failure | Phase 1 / Phase 2 | Unknown | University Medical Centre Ljubljana | 40 | 2024-07-01 | 2024-07-15 |
| BIO 300 Oral Powder Safety and Pharmacokinetics BIO 300 Oral Powder - Acute Radiation Syndrome | Phase 1 | Completed | Humanetics Corporation | 34 | 2020-12-08 | 2024-05-03 |
| Genistein Supplementation to Mitigate Cardiometabolic Dysfunction in Patients Undergoing Androgen Deprivation Therapy for Prostate Cancer Genistein, Placebo - Prostate Cancer | Phase 2 | Terminated | Emory University | 10 | 2017-10-16 | 2022-09-27 |
| Genistein as a Possible Treatment for Alzheimer's Disease. Genistein, Placebo - Alzheimer's Disease | Not applicable | Completed | Fundación para la Investigación del Hospital Clínico de Valencia | 27 | 2017-09-01 | 2021-09-10 |
| Study of Genistein in Reducing Side Effects of Superficial Bladder Cancer Treatment Genistein, Sugar pill - Bladder Cancer | Phase 2 | Completed | Emory University | 36 | 2017-05-19 | 2025-02-05 |
| Study of Genistein in Pediatric Oncology Patients (UVA-Gen001) Genistein, Placebo - Lymphoma, Childhood Lymphoma | Phase 2 | Terminated | University of Virginia | 4 | 2016-08-01 | 2024-05-06 |
| BIO 300 Non-Small Cell Lung Cancer Study BIO 300 Oral Suspension, Paclitaxel, Carboplatin - Carcinoma, Non-Small-Cell Lung | Phase 1 / Phase 2 | Completed | Humanetics Corporation | 21 | 2015-11-01 | 2024-01-25 |
| Phase I/II a Study of Decitabine in Combination With Genistein in Pediatric Relapsed or Refractory Malignancies Decitabine and Genistein - Cancer | Phase 1 / Phase 2 | Completed | St. Justine's Hospital | 6 | 2015-07-01 | 2017-11-17 |
| Effect of Enteral Genistein Supplementation in Sepsis Genistein, enteral nutrition only - Sepsis | Phase 4 | Unknown | TC Erciyes University | 30 | 2015-06-01 | 2016-06-13 |
| Isoflavone Treatment for Postmenopausal Osteopenia. Red clover extract, Supplementation (placebo) - Osteopenia, Osteoporosis | Not applicable | Completed | University of Aarhus | 85 | 2014-06-01 | 2023-12-04 |
| Soy Isoflavone in Combination With Radiation Therapy and Cisplatin in SCC of the Head and Neck Soy isoflavone, Radiation, Cisplatin - Cancer of Head and Neck | Phase 1 | Completed | Emory University | 24 | 2013-11-01 | 2019-12-06 |
| Genistein in Treatment of Metastatic Colorectal Cancer Genistein - Colon Cancer, Rectal Cancer | Phase 1 / Phase 2 | Completed | Sofya Pintova | 13 | 2013-11-01 | 2019-05-10 |
Showing 20 of 46. Sign in to see all of them.
Prostatic Neoplasms (8) · Breast Neoplasms (4) · Osteoporosis (4) · Carcinoma, Non-Small-Cell Lung (3) · Inflammation (3) · Metabolic Syndrome (3) · Neoplasms (3) · Pancreatic Neoplasms (3) · Alzheimer Disease (2) · Bone Diseases, Metabolic (2) · Carcinoma, Renal Cell (2) · Cardiovascular Diseases (2) · Cystic Fibrosis (2) · Glucose Intolerance (2) · Kidney Neoplasms (2)
National Cancer Institute (NCI) (4) · Emory University (3) · Northwestern University (3) · University of Messina (3) · Barbara Ann Karmanos Cancer Institute (2) · Children's Hospital of Philadelphia (2) · Humanetics Corporation (2) · London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's (2) · UNC Lineberger Comprehensive Cancer Center (2) · University of Reading (2) · Axcentua Pharmaceuticals AB (1) · Creighton University (1) · Fundación para la Investigación del Hospital Clínico de Valencia (1) · Imperial College London (1) · Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran (1)
United States (21) · Canada (4) · United Kingdom (3) · China (2) · Italy (2) · Spain (2) · Denmark (1) · Norway (1) · Slovenia (1) · Sweden (1) · Taiwan (1) · Turkey (Türkiye) (1)
Francesco Squadrito, MD (3) · Claire Williams, PhD (2) · Daniel Lamport, PhD (2) · Luke R Till, MSc (2) · Mark JK Chandy, MD PhD (2) · Ronald Rubenstein, M.D., PhD. (2) · Amy Weise, DO (1) · Bato Lazarevic, MD (1) · David Jarrard (1) · Donna Kritz-Silverstein (1) · Edward Garon, MD (1) · Fazlul H. Sarkar, PhD (1) · Henrique Bittencourt, MD (1) · Howard H Bailey (1) · J C Gallagher (1)
PMID 33331662, PMID 37983082, PMID 17577003, PMID 18446090, PMID 22293631, PMID 22307566, PMID 23899172, PMID 28489488, PMID 28768651, PMID 31203390, PMID 36301689, PMID 36329553
N01CN35153 (2), P30CA022453 (2), N01CN35157 (1), P30CA014520 (1), P30CA138292 (1), P50CA090386 (1), R01HL057790 (1)